Featured 13F manager
SurgoCap Partners LP Mala Gaonkar
New York, NY 11 processed 13Fs on this site · 2023 Q4–2026 Q2
- $3.1B
- 13 Positions
- 2026 Q2
- +3.3% QoQ
- Top 5 57.9%
Mala Gaonkar files SurgoCap Partners LP as a Form 13F. The latest book is 2026 Q2 at $3.1B, up 3.3% QoQ, led by Taiwan Semiconductor, Carpenter Technology, and Alphabet.
Portfolio
top 5 57.9% · top 10 92.2%
- TSM - Taiwan Semiconductor 14.0%
- CRS - Carpenter Technology 13.7%
- GOOG - Alphabet · CL C 11.0%
- LPLA - Lpl Finl 9.7%
- MDLN - Medline · CL A 9.5%
- MCK - Mckesson 9.2%
- INTC - Intel 8.3%
- GLW - Corning 6.6%
- V - VISA · CL A 6.3%
- AGX - Argan 3.9%
- NU — · CL A 3.5%
- ISRG - Intuitive Surgical 3.3%
- Other 1.0%
AUM over time
Book
| MSFT - Microsoft | 11.93% | Hold | 454,258 | $376.04 | $171M |
| MCK - Mckesson | 10.77% | Hold | 333,028 | $462.98 | $154M |
| LPLA - Lpl Finl | 9.16% | Hold | 576,619 | $227.62 | $131M |
| BX - Blackstone | 8.48% | Hold | 927,596 | $130.92 | $121M |
| GE - GE Aerospace | 8.23% | Hold | 923,096 | $127.63 | $118M |
| META - Meta Platforms · CL A | 7.12% | Hold | 288,218 | $353.96 | $102M |
| PTC - PTC Inc | 6.45% | Hold | 528,045 | $174.96 | $92M |
| SNPS - Synopsys | 6.34% | Hold | 176,485 | $514.91 | $91M |
| PANW - Palo Alto Networks | 6.15% | Hold | 298,944 | $294.88 | $88M |
| NU — · CL A | 5.79% | Hold | 9,950,708 | $8.33 | $83M |
| NVDA - Nvidia | 5.48% | Hold | 158,364 | $495.22 | $78M |
| GEHC - GE HealthCare | 5.00% | Hold | 925,554 | $77.32 | $72M |
| HLT - Hilton | 4.03% | Hold | 316,863 | $182.09 | $58M |
| ISRG - Intuitive Surgical | 3.92% | Hold | 166,338 | $337.36 | $56M |
Filings history
11 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 13 | $3.1B | +3.3% | 13F-HR | 8/13/2026 | 000091957426005191 |
| 2026 Q1 | 14 | $3B | −17.1% | 13F-HR | 5/15/2026 | 000091957426003167 |
| 2025 Q4 | 17 | $3.6B | +0.4% | 13F-HR | 2/17/2026 | 000091957426001016 |
| 2025 Q3 | 16 | $3.6B | +35.8% | 13F-HR | 11/13/2025 | 000091957425006748 |
| 2025 Q2 | 13 | $2.6B | +30.8% | 13F-HR | 8/14/2025 | 000091957425004655 |
| 2025 Q1 | 12 | $2B | +4.3% | 13F-HR | 5/15/2025 | 000091957425003084 |
| 2024 Q4 | 12 | $1.9B | −3.1% | 13F-HR | 2/14/2025 | 000091957425001210 |
| 2024 Q3 | 12 | $2B | +17.1% | 13F-HR | 11/14/2024 | 000091957424006446 |
| 2024 Q2 | 13 | $1.7B | −8.2% | 13F-HR | 8/14/2024 | 000091957424004550 |
| 2024 Q1 | 14 | $1.9B | +30.1% | 13F-HR | 5/15/2024 | 000091957424003006 |
| 2023 Q4 | 15 | $1.4B | — | 13F-HR | 2/14/2024 | 000091957424001147 |
About
SurgoCap Partners LP
11 processed 13Fs on this site · 2023 Q4–2026 Q2